LQDA: Liquidia Corporation Stock

by  •  • Comments Off on LQDA: Liquidia Corporation Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 875.35
Enterprise Value ($M) 801.85
Book Value ($M) 86.26
Book Value / Share 1.13
Price / Book 10.15
NCAV ($M) 57.08
NCAV / Share 0.75
Price / NCAV 15.34

Profitability (mra)
Return on Invested Capital (ROIC) -0.62
Return on Assets (ROA) -0.89
Return on Equity (ROE) -1.78

Liquidity (mrq)
Quick Ratio 7.50
Current Ratio 7.66

Balance Sheet (mrq) ($M)
Current Assets 167.94
Assets 197.12
Liabilities 110.86
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 17.49
Operating Income -73.38
Net Income -78.50

Cash Flow Statement (mra) ($M)
Cash From Operations -41.56
Cash from Investing -11.29
Cash from Financing 43.25

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Manning Paul B 9.20 5.06
02-07 13G/A BlackRock Inc. 4.97 -3.33
01-16 13G Legend Aggregator, LP 9.50
12-14 13D/A Caligan Partners LP 15.30 44.55

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-07-26 63,471 379,626 16.72
2024-07-25 103,240 395,793 26.08
2024-07-24 115,831 706,207 16.40
2024-07-23 393,223 1,030,900 38.14
2024-07-22 201,053 672,185 29.91

(click for more detail)

Similar Companies
LIXT – Lixte Biotechnology Holdings, Inc. LPCN – Lipocine Inc.
LPTX – Leap Therapeutics, Inc. LSDI – Lucy Scientific Discovery Inc.
LSTA – Lisata Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io